ArticleEmerging infectious diseases2011
Hepatitis a virus vaccine escape variants and potential new serotype emergence.
Article in Emerging infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Article
- Divergent Genotype of Hepatitis A Virus in Alpacas, Bolivia, 2019.Emerging infectious diseases · 2023Article
- Hepatitis A virus infection.Nature reviews. Disease primers · 2023Review
- Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking.International journal of molecular sciences · 2022Article
- Acute Hepatitis A Viral Infection in People With HIV With Previously Documented Hepatitis A Immunity or Appropriate Vaccination: A Case Series.Open forum infectious diseases · 2021Article
- Article
- Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.Human vaccines & immunotherapeutics · 2021Review
- Article
- Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.Cold Spring Harbor perspectives in medicine · 2019Review
- Structural basis for neutralization of hepatitis A virus informs a rational design of highly potent inhibitors.PLoS biology · 2019Article
- Toward development of generic inhibitors against the 3C proteases of picornaviruses.The FEBS journal · 2019Article
- Temporal Dynamics of Co-circulating Lineages of Porcine Reproductive and Respiratory Syndrome Virus.Frontiers in microbiology · 2019Article
- Evidence for positive selection of hepatitis A virus antigenic variants in vaccinated men-having-sex-with men patients: Implications for immunization policies.EBioMedicine · 2019Article
- Hepatitis A Virus Codon Usage: Implications for Translation Kinetics and Capsid Folding.Cold Spring Harbor perspectives in medicine · 2018Review
- Challenges in dengue research: A computational perspective.Evolutionary applications · 2018Review
- Foodborne viruses.Current opinion in food science · 2016Review
- Hepatitis A virus genotype distribution during a decade of universal vaccination of preadolescents.International journal of molecular sciences · 2015Article
- Molecular biology and inhibitors of hepatitis A virus.Medicinal research reviews · 2014Review
- Hepatitis B and E co-primary infections in an HIV-1-infected patient.Journal of clinical microbiology · 2013Article
- Genetic diversity of hepatitis A virus in China: VP3-VP1-2A genes and evidence of quasispecies distribution in the isolates.PloS one · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Six hepatitis A virus antigenic variants that likely escaped the protective effect of available vaccines were isolated, mostly from men who have sex with men. The need to complete the proper vaccination schedules is critical, particularly in the immunocompromised population, to prevent the emergence of vaccine-escaping variants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.